Dengue Vaccine Phase 3 Clinical Trials: The first and second phase trials of dengue vaccine have been completed. In these, the vaccine has proved to be very beneficial. Now the trial of the next phase will also start soon. A senior officer has said this to the news agency ANI. This vaccine has been developed in collaboration with the Indian Council of Medical Research (ICMR). Let us tell you that the Phase 3 trial of the vaccine is going to start soon.
how long will the trial be
According to media reports, Phase 3 trial may begin in August this year, which will test the efficiency of the vaccine as well as the safety and immunity boosted by the vaccine. The vaccine prepared by the manufacturers is all set for Phase-3 trial.
Dengue is a mosquito-borne disease caused by four different viruses. This disease is a major public health problem in many parts of the country. Many types of symptoms are seen in dengue. In this, the patient gets caught from mild fever to serious illness. It also includes Dengue Hemorrhagic Fever.
Dengue deaths occur every year
Dengue kills every year in India. Its cases increase significantly during the rainy season. Dengue can lead to shock syndrome. About 3 lakh people are infected with dengue every year in India. 90 percent of the patients of this disease are cured by treatment, but till date there is no prescribed treatment for dengue.
The patient is treated only on the basis of symptoms. If platelets become less than 20 thousand, then there is a danger of the condition becoming serious. This disease makes people of any age a victim.
